HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Parham Selected Research

Peter Parham Research Topics

Disease

12Infections
11/2018 - 05/2003
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 06/2007
6Neoplasms (Cancer)
01/2022 - 01/2002
5Leukemia
01/2021 - 05/2003
4Virus Diseases (Viral Diseases)
01/2018 - 01/2012
3Malaria
01/2023 - 01/2012
3Acquired Immunodeficiency Syndrome (AIDS)
01/2011 - 06/2007
2Parkinson Disease (Parkinson's Disease)
01/2020 - 01/2019
2Persistent Infection
10/2015 - 11/2014
2Pre-Eclampsia (Preeclampsia)
01/2015 - 11/2010
2Cerebral Malaria
10/2013 - 01/2012
2Communicable Diseases (Infectious Diseases)
06/2011 - 08/2010
2HIV Infections (HIV Infection)
01/2011 - 06/2007
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019
1Neuroinflammatory Diseases
01/2019
1Behcet Syndrome (Behcet's Syndrome)
01/2019
1Rheumatoid Arthritis
01/2019
1Tuberculosis (Tuberculoses)
01/2019
1Drug Hypersensitivity (Drug Allergy)
11/2018
1Drug-Related Side Effects and Adverse Reactions
11/2018
1Cytomegalovirus Infections (Inclusion Disease)
01/2018
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2016
1Disease Resistance
10/2013
1Myeloid Leukemia (Leukemia, Myelocytic)
06/2007
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2007
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2007
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2007
1Human Influenza (Influenza)
03/2007
1Vaccinia
01/2006
1Autoimmune Diseases (Autoimmune Disease)
03/2005
1Disease Susceptibility (Diathesis)
02/2005
1Lymphoma (Lymphomas)
02/2003

Drug/Important Bio-Agent (IBA)

9KIR ReceptorsIBA
01/2020 - 06/2006
9LigandsIBA
05/2014 - 05/2003
7HLA-B Antigens (HLA-B)IBA
01/2023 - 06/2007
7HLA-C Antigens (HLA-C)IBA
01/2018 - 11/2010
4Peptides (Polypeptides)IBA
01/2023 - 01/2017
4Immunoglobulins (Immunoglobulin)IBA
01/2019 - 05/2003
4EpitopesIBA
01/2019 - 01/2015
4HLA Antigens (Human Leukocyte Antigens)IBA
11/2018 - 05/2003
3AntigensIBA
01/2023 - 01/2018
3CytokinesIBA
01/2022 - 01/2012
3Natural Killer Cell ReceptorsIBA
10/2015 - 03/2007
2VaccinesIBA
01/2019 - 11/2014
2NK Cell Lectin-Like Receptor Subfamily CIBA
01/2018 - 01/2006
2Histocompatibility Antigens Class IIBA
05/2015 - 01/2002
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2023
1HLA-DRB1 Chains (HLA DRB1)IBA
01/2019
1Amino AcidsFDA Link
01/2019
1Valine (L-Valine)FDA Link
01/2019
1HLA-B57 antigenIBA
11/2018
1Viral AntigensIBA
01/2018
1RNA (Ribonucleic Acid)IBA
06/2007
1N 556IBA
06/2007
1Proteins (Proteins, Gene)FDA Link
03/2007
1Poly I-CIBA
03/2007
1Hemagglutinins (Hemagglutinin)IBA
03/2007
1Carrier Proteins (Binding Protein)IBA
03/2007

Therapy/Procedure

12Transplantation
01/2021 - 05/2003
6Cell Transplantation
01/2021 - 02/2003
2Immunotherapy
01/2022 - 08/2016
2Therapeutics
01/2019 - 11/2014
2Donor Selection
05/2014 - 10/2010
1Hematopoietic Stem Cell Transplantation
01/2016
1Stem Cell Transplantation
03/2005
1Homologous Transplantation
02/2005